Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Capital/Financing Update 2022

Dec 30, 2022

6990_rns_2022-12-30_73c4847f-6f0f-4097-b070-c09d07f8960f.htm

Capital/Financing Update

Open in viewer

Opens in your device viewer

FORM D false

����� ���� 2 380
PLURI INC
Corporation no: C12337-2001 8543
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 30/12/2022
www.isa.gov.il www.tase.co.il Reference: 2022-02-124899 Time of broadcast: 16:53 16:53

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onFORM D

ea171020-d_pluriincEDGAR3_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 29/12/2022
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity: PLURISTEM THERAPEUTICS INC
Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1